Cellular Therapeutics
Living-cell preparations developed for their capacity to interact with tissues, immune systems and local biological environments. This category includes MSC-based and selected immune-cell technologies.
Our Technologies
A multidisciplinary platform for regenerative and cellular medicine.
CELLMEX develops and evaluates cellular, cell-free and immune-based biotechnology platforms. Our work includes mesenchymal stromal cells, extracellular vesicles, secretome-derived preparations, conditioned-media technologies, lineage-directed cells and selected immune-cell applications.
Technology Overview
More than a single stem-cell platform
Regenerative medicine encompasses several distinct biological approaches. These include living-cell therapies, cell-free signalling products, tissue-directed cellular systems and immune-cell technologies.
Each platform has a different biological identity, proposed mechanism, manufacturing process, characterisation strategy and clinical purpose.
For this reason, CELLMEX does not treat terms such as stem cells, exosomes, secretome and conditioned media as interchangeable.
Each technology requires its own scientific, clinical, quality and regulatory assessment.
Platform Categories
Three interconnected areas of biotechnology
The CELLMEX technology portfolio is organised into cellular therapeutics, cell-free biologics and advanced cellular development platforms.
Cell-Free Biologics
Preparations derived from cellular signalling products rather than intact living cells. These may include extracellular vesicles, soluble mediators and defined secretome fractions.
Advanced Cell Development
Technologies involving directed cellular differentiation, tissue-specific phenotypes, specialised manufacturing processes and translational research applications.
Technology Portfolio
Explore each CELLMEX technology platform
Select a technology to review its biological basis, manufacturing considerations, proposed applications, characterisation requirements and clinical context.
Cellular Therapeutics
MSC Therapy
Mesenchymal stromal cell platforms developed for their immunomodulatory, anti-inflammatory, trophic and tissue-supporting biological activity.
Principal focus
Living-cell therapy, paracrine signalling,
immune modulation and tissue-repair support.
Explore MSC Therapy →
Cell-Free Biologics
Purified Exosomes
Highly enriched extracellular-vesicle preparations intended to separate vesicular signalling components from broader conditioned-media constituents.
Principal focus
Vesicle enrichment, purification, particle
characterisation and molecular cargo analysis.
Explore Purified Exosomes →
Cell-Free Biologics
Small Extracellular Vesicles
Nano-scale extracellular-vesicle populations released by cells and studied as mediators of intercellular communication and biological signalling.
Principal focus
Particle size, concentration, morphology,
identity markers, purity and functional activity.
Explore Small Extracellular Vesicles →
Cell-Free Biologics
MSC Secretome
The complete group of soluble and vesicular factors released by mesenchymal stromal cells under defined culture conditions.
Principal focus
Cytokines, growth factors, chemokines,
extracellular vesicles and other secreted
biological mediators.
Explore MSC Secretome →
Cell-Free Biologics
Conditioned Media
Cell-culture medium collected after exposure to living cells and containing a mixture of soluble proteins, metabolites and extracellular particles.
Principal focus
Culture conditions, collection parameters,
concentration, sterility and compositional
consistency.
Explore Conditioned Media →
Cell-Free Biologics
Exosome-Depleted Conditioned Media
Conditioned-media preparations processed to reduce or remove selected extracellular-vesicle fractions while retaining soluble secreted factors.
Principal focus
Separation of vesicular and non-vesicular
biological activity for research and product
development.
Explore Exosome-Depleted Media →
Advanced Cell Development
Differentiated MSCs
Mesenchymal stromal cells guided toward selected tissue-associated phenotypes through controlled culture, signalling and differentiation protocols.
Principal focus
Lineage direction, phenotype confirmation,
functional testing and tissue-specific research.
Explore Differentiated MSCs →
Immune Cell Technologies
Immune Cell Therapies
Cellular platforms involving the isolation, activation, expansion or functional modification of selected immune-cell populations.
Principal focus
Immune-cell identity, activation state,
functional potency, safety and indication-specific
development.
Explore Immune Cell Therapies →
Technology Development
From biological concept to controlled application
Each technology requires a defined development pathway before it can be responsibly positioned for research, clinical evaluation or commercial use.
Biological Definition
Establish the source material, intended product identity and biological classification.
Process Development
Define culture, isolation, purification, concentration and storage conditions.
Characterisation
Confirm identity, composition, purity, viability, potency and relevant quality attributes.
Clinical Positioning
Evaluate the biological rationale, supporting evidence, route of administration and target use.
Quality and Regulatory Review
Assess manufacturing controls, documentation, safety requirements and applicable regulatory pathways.
Scientific and Clinical Context
Technology descriptions are not treatment claims
Important scientific qualification
The presence of a technology on this website does not establish that it is approved, clinically proven or suitable for every patient or medical condition.
Some cellular and immune-cell therapies have established uses in specific medical settings. Other applications involving MSCs, extracellular vesicles, exosomes, secretome products, conditioned media or differentiated cells remain investigational or require additional clinical validation.
Product identity, source material, manufacturing, characterisation, potency, safety, intended use and applicable regulatory requirements must be evaluated separately for each technology.
Explore CELLMEX
Select the technology most relevant to your interests
Detailed pages will provide additional scientific, manufacturing, quality and clinical information for each platform.